Table 1. Patient demographics and medications by ward.
| Characteristics | Ward | Total N = 604 | ||
| Men N = 253 | Women N = 230 | Geriatric N = 121 | ||
| Mean age [SD], (range), years | 38.8 [10.3] (18–65) | 42.5 [11.0] (19–64) | 67.3 [6.2] (60–85) | 45.9 [14.7] |
| Gender, % (n) | ||||
| Male | 100.0% (253) | 0.0% (0) | 49.6% (60) | 51.8% (313) |
| Female | 0.0% (0) | 100.0% (230) | 50.4% (61) | 48.2% (291) |
| Diagnosis, % (n) | ||||
| Schizophrenia | 86.6% (219) | 72.2% (176) | 80.2% (87) | 79.8% (482) |
| 1. Schizophrenia | 68.0% (172) | 53.0% (122) | 66.1% (80) | 61.9% (374) |
| 2. Paranoid | 3.6% (9) | 0.0% (0) | 0.0% (0) | 1.5% (9) |
| 3. Hebephrenic | 4.0% (10) | 10.4% (24) | 3.3% (4) | 6.3% (38) |
| 4. Catatonic | 0.4% (1) | 0.9% (2) | 0.0% (0) | 0.5% (3) |
| 5. Undifferentiated | 1.6% (4) | 0.4% (1) | 0.8% (1) | 1.0% (6) |
| 6. Residual | 4.7% (12) | 0.9% (2) | 8.3% (10) | 4.0% (24) |
| 7. Simple | 0.4% (1) | 0.0% (0) | 0.0% (0) | 0.2% (1) |
| 8. Unspecified | 4.0% (10) | 6.5% (15) | 1.7% (2) | 4.5% (27) |
| Schizoaffective disorder | 13.4% (34) | 27.8% (64) | 19.8% (24) | 20.2% (122) |
| 1. Schizoaffective disorders | 12.3% (31) | 21.7% (50) | 17.4% (21) | 16.9% (102) |
| 2. Depressive type | 0.0% (0) | 3.9% (9) | 0.0% (0) | 1.5% (9) |
| 3. Mixed type | 0.4% (1) | 1.7% (4) | 0.8% (1) | 1.0% (6) |
| 4. Unspecified | 0.8% (2) | 0.4% (1) | 1.7% (2) | 0.8% (5) |
| Drug/Drug types a , % (n) | ||||
| Sodium valproate | 20.9% (53) | 19.1% (44) | 11.6% (14) | 18.4% (111) |
| Typical antipsychotics b | 61.2% (155) | 77.8% (179) | 27.3% (33) | 60.8% (367) |
| Number | ||||
| 1 | 55.7% (141) | 64.8% (149) | 24.8% (30) | 53.0% (320) |
| 2 | 5.1% (13) | 12.6% (29) | 2.5% (3) | 7.5% (45) |
| 3 | 0.4% (1) | 0.4% (1) | 0.0% (0) | 0.3% (2) |
| Atypical antipsychotics c | 55.7% (141) | 65.6% (151) | 85.9% (104) | 65.6% (396) |
| Number | ||||
| 1 | 47.0% (119) | 54.3% (125) | 76.0% (92) | 55.6% (336) |
| 2 | 8.7% (22) | 11.3% (26) | 9.1% (11) | 9.8% (59) |
| 3 | 0.0% (0) | 0.0% (0) | 0.8% (1) | 0.2% (1) |
| Antidepressants d | 9.5% (24) | 3.9% (9) | 0.8% (1) | 5.6% (34) |
| Number | ||||
| 1 | 9.1% (23) | 3.5% (8) | 0.8% (1) | 5.3% (32) |
| 2 | 0.4% (1) | 0.4% (1) | 0.0% (0) | 0.3% (2) |
| Anxiolytics e | 58.9% (149) | 42.1% (97) | 23.4% (27) | 45.2% (273) |
| Number | ||||
| 1 | 57.3% (145) | 40.4% (93) | 20.7% (25) | 43.5% (263) |
| 2 | 1.6% (4) | 1.7% (4) | 1.7% (2) | 1.7% (10) |
| Mood stabilizers f | 8.7% (22) | 8.3% (79) | 9.9% (12) | 8.3% (53) |
| Number | ||||
| 1 | 8.3% (21) | 7.4% (17) | 9.9% (12) | 8.3% (50) |
| 2 | 0.4% (1) | 0.9% (2) | 0.0% (0) | 0.5% (3) |
| Sleeping pills g | 66.8% (169) | 34.8% (80) | 79.3% (96) | 57.1% (345) |
a
Totals might exceed 100% because some patients received more than one drug type.
b
chlorpromazine, flupentixol, fluphenazine, haloperidol, levomepromazine, penfluridol, perhphenazine, zuclopenthixol.
c
amisulpride, aripriprazole, asenapine, clotiapine, clozapine, olanzapine, paliperidone, palperidone, quetiepine, risperidone, sertindole, ziprasidone.
d
escitalopram, paroxetine, reboxetine, trazadone.
e
buspirone, clonazepam, diazepam, lorazepam, oxazepam.
f
carbamazepine, lamotrigine, lithium.
g
brotizolam, nitrazepam, zopiclone.